ATE133074T1 - Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen - Google Patents

Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen

Info

Publication number
ATE133074T1
ATE133074T1 AT91906129T AT91906129T ATE133074T1 AT E133074 T1 ATE133074 T1 AT E133074T1 AT 91906129 T AT91906129 T AT 91906129T AT 91906129 T AT91906129 T AT 91906129T AT E133074 T1 ATE133074 T1 AT E133074T1
Authority
AT
Austria
Prior art keywords
immune response
agents
boost
inducing
mammals
Prior art date
Application number
AT91906129T
Other languages
English (en)
Inventor
Jerome A East Th Stre Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE133074T1 publication Critical patent/ATE133074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT91906129T 1990-03-21 1991-03-19 Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen ATE133074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21

Publications (1)

Publication Number Publication Date
ATE133074T1 true ATE133074T1 (de) 1996-02-15

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906129T ATE133074T1 (de) 1990-03-21 1991-03-19 Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen

Country Status (19)

Country Link
EP (1) EP0521916B1 (de)
JP (1) JPH05505799A (de)
CN (1) CN1055116A (de)
AT (1) ATE133074T1 (de)
AU (1) AU656889B2 (de)
CA (1) CA2078676A1 (de)
DE (1) DE69116552T2 (de)
DK (1) DK0521916T3 (de)
ES (1) ES2082201T3 (de)
FI (1) FI924215L (de)
GR (1) GR3019018T3 (de)
HU (1) HUT63062A (de)
IE (1) IE72204B1 (de)
IL (1) IL97600A0 (de)
MY (1) MY108672A (de)
OA (1) OA09672A (de)
PT (1) PT97082B (de)
WO (1) WO1991014450A1 (de)
ZA (1) ZA912037B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
AU9161591A (en) * 1990-12-19 1992-07-22 Schering Corporation Use of il-4 to enhance immune response to immunogens in vaccines
JPH0747545B2 (ja) * 1991-01-10 1995-05-24 シェリング・コーポレーション 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
CZ38095A3 (en) * 1992-08-19 1995-12-13 Schering Corp Pharmaceutical preparation for treating hiv infection, process of its preparation, il-4 and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
EP0302429B1 (de) * 1987-08-03 1993-07-28 Tasuku Honjo Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
CA2045574A1 (en) * 1989-01-20 1990-07-21 John A. Hamilton Fibrinolysis

Also Published As

Publication number Publication date
IE72204B1 (en) 1997-04-09
CN1055116A (zh) 1991-10-09
FI924215A7 (fi) 1992-09-21
OA09672A (en) 1993-05-15
DK0521916T3 (da) 1996-03-04
PT97082A (pt) 1991-11-29
ES2082201T3 (es) 1996-03-16
AU7469091A (en) 1991-10-21
WO1991014450A1 (en) 1991-10-03
FI924215A0 (fi) 1992-09-21
MY108672A (en) 1996-10-31
AU656889B2 (en) 1995-02-23
IL97600A0 (en) 1992-06-21
DE69116552T2 (de) 1996-05-30
GR3019018T3 (en) 1996-05-31
EP0521916A1 (de) 1993-01-13
IE910921A1 (en) 1991-09-25
JPH05505799A (ja) 1993-08-26
DE69116552D1 (de) 1996-02-29
FI924215L (fi) 1992-09-21
HUT63062A (en) 1993-07-28
PT97082B (pt) 1998-07-31
EP0521916B1 (de) 1996-01-17
CA2078676A1 (en) 1991-09-22
ZA912037B (en) 1992-03-25

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
DK641889A (da) Anvendelse af en blodpladeaktiveringsfaktorantagonist i kombination med monoklonale eller polyklonale antistoffer i et farmaceutisk praeparat til behandling af endotoksisk chok hos pattedyr
ATE192931T1 (de) Morphogen-induzierte modulation von entzündlichen antworten
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
PT750513E (pt) Complexos proteina de stress-peptido como vacinas profilacticas e terapeuticas contra patogenios intracelulares
SE437837B (sv) Polypeptid for att kontrollera och/eller forbettra reproduktionen hos djur jemte veteriner komposition innehallande nemnda polypeptid som aktiv bestandsdel
DK0911033T3 (da) Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis
DE69130071D1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
ATE54826T1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ATE133074T1 (de) Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen
DE69114519D1 (de) Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
ATE190351T1 (de) Polypeptide, von endonexin 2 stammend, mit hepatitis b virus rezeptor aktivität und deren verwendungen in diagnotischen und pharmazeutischen zusammensetzungen
ES2036526T3 (es) Composiciones de interferon.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ATE229981T1 (de) Glykolisierte cytokine
FI810380L (fi) Fenylpiperazinderivat av 1,3,4-oxadiazolylfenoler deras framstaellning och dessa innehaollande terapeutiska aemnen
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
ES2160927T3 (es) Composiciones farmaceuticas que comprenden interferon alfa humano natural.
OA08768A (fr) Traitement du virus su SIDA par l'interféron alpha humain recombinant.
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств
DK0495721T3 (da) Anvendelsen af et polypeptid med en humant-interleukin-2-aktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af pneumothorax